This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September 2026 quarter: revenue up 39%, profit after tax up 122%, cash flow negative
PRASOLCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the standalone quarter ended September 30, 2026, revenue from operations was ₹4,125.66 million, up 38.6% from ₹2,976.50 million a year earlier; profit after tax was ₹379.75 million, up 121.9% from ₹171.12 million. Operating margin before interest, tax, depreciation and amortisation rose from 10.4% to 14.0%. Standalone half-year net profit was ₹989.98 million and operating cash flow was negative ₹117.14 million. The IPO raised ₹5,000 million.
Strong growth and a wider operating margin support sentiment; IPO brought fresh funds, but negative operating cash flow remains a near-term risk.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹412.6 Cr | — | — |
| Operating profit | ₹49.08 Cr | — | — |
| Profit after tax | ₹37.98 Cr | — | — |
| EBITDA margin | 14.0% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.